HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of laser-induced choroidal neovascularization by subconjunctival injection of 9alpha-fluoromedroxyprogesterone acetate (FMPA), an anti-angiogenic agent, in rats.

Abstract
9alpha-Fluoromedroxyprogesterone acetate (FMPA) is a synthetic analog of medroxyprogesterone acetate (MPA). FMPA exhibited more potent anti-tumor and anti-angiogenic activities in some assay systems than the parent agent, MPA. Exudative age-related macular degeneration (AMD) is characterized by choroidal neovascularization (CNV). Anecortave acetate, an angiostatic steroid, is clinically efficacious in patients with exudative AMD. Betamethasone is an anti-angiogenic steroid. Therefore, we examined the effects of FMPA, anecortave acetate and betamethasone on laser-induced CNV in rats. Anecortave acetate and betamethasone were included as positive controls. Crypton laser was applied to the fundus in Brown Norway rats. Laser photocoagulations were performed in each eye between the major retinal vessels of the superior retina. Subconjunctival injection of FMPA, anecortave acetate or betamethasone was performed once just after the photocoagulation (on day 0). The incidence of CNV formation was evaluated by fluorescein angiography (FAG) on day 14. On the next day, examination of the retinal function was performed by electro retinogram (ERG). Subconjunctival injection of FMPA at doses of 300, 1000 and 3000 microg/eye dose-dependently inhibited the incidence of CNV formation. Significant differences were observed at doses of 1000 and 3000 microg/eye of FMPA as compared with the control group. Anecortave acetate and betamethasone significantly inhibited the incidence of CNV formation. FMPA at the doses used in this study did not affect the retinal function in rats, as determined by ERG. FMPA appeared to be effective in a rat model of CNV, so it was demonstrated that FMPA might be useful in the treatment of AMD.
AuthorsNatsuko Murata, Taketo Yamaji, Masayuki Uchida, Hiroshi Tsuboi, Hiroto Suzuki, Masashi Yamada, Tsutomu Oikawa, Junko Nobuhiro, Tominari Choshi, Satoshi Hibino
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 29 Issue 12 Pg. 2410-4 (Dec 2006) ISSN: 0918-6158 [Print] Japan
PMID17142973 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 17-acetoxy-9-fluoro-6-methylprogesterone
  • Angiogenesis Inhibitors
  • Progesterone
Topics
  • Angiogenesis Inhibitors (administration & dosage, pharmacology)
  • Animals
  • Choroidal Neovascularization (etiology, prevention & control)
  • Conjunctiva
  • Electroretinography
  • Lasers
  • Male
  • Progesterone (administration & dosage, analogs & derivatives, pharmacology)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: